Open tender · Germany · Pharmaceutical products
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Teriflunomid, ATC L04AK02 für die Zeit 01.10.2025 - 31.12.2025 (zzgl. Verlängerungsoption 1x12 Monate)
In EnglishConclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Teriflunomide, ATC L04AK02 for the period 01.10.2025 - 31.12.2025 (plus extension option 1x12 months)
DAK-Gesundheit in Germany is inviting bids for “Conclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Teriflunomide, ATC L04AK02 for the period…”. Bids close on 5 November 2026, 12:00 CET. askTender lists every requirement to qualify and checks whether your company meets them.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
The requirements to qualify, the eligibility check and the bid documents for this tender are in your askTender account.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences